vimarsana.com

Card image cap

Dr. Usmani, MD, MBA, FACP provides insights into Selinexor's safety profile in Relapsed/Refractory Multiple Myeloma (R/R MM), comparing it with other treatments and delve into the ongoing challenges and unmet needs in R/R MM patient care.

Related Keywords

, Clinical Experience , Refractory Multiple Myeloma , Myeloma , Multiple Myeloma , Xpo1 Inhibitors , Rapid Readouts , Evolving Role Of Xpo1 Inhibitors In Multiple Myeloma , Xp01 , Xpo1 ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.